Highly successful treatment outcome of multidrug-resistant tuberculosis in the Netherlands, 2000-2009

Autor: Cecile Magis-Escurra, D. van Soolingen, de Wiel Lange, S van den Hof, C. H. Haar, van der Tjipke Werf, R. van Altena, Martin J. Boeree, G. de Vries

Publikováno v: International Journal of Tuberculosis and Lung Disease, 19, 4, pp. 406-12
international journal of tuberculosis and lung disease, 19(4), 406-412. International Union Against Tuberculosis and Lung Disease (The Union)
International Journal of Tuberculosis and Lung Disease, 19, 406-12
International Journal of Tuberculosis and Lung Disease, 19(4), 406-412. International Union against Tubercul. and Lung Dis.

SETTING: Resistance to the two key anti-tuberculosis drugs isoniazid and rifampicin is a characteristic of multidrug-resistant tuberculosis (MDR-TB). MDR-TB is a scourge requiring toxic, prolonged treatment and is associated with poor outcomes. The N

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aef5ecef6a27f10d46d5d8fbb4a6f50e
https://doi.org/10.5588/ijtld.14.0838

HIV-related mortality among tuberculosis patients in The Netherlands, 1993-2001

Autor: C H, Haar, F G J, Cobelens, N A, Kalisvaart, P J H J, van Gerven, J J, van der Have

Publikováno v: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease. 11(9)

Human immunodeficiency virus (HIV) infection in tuberculosis (TB) patients in The Netherlands during the period 1993-2001 was associated with an increased risk of death (adjusted odds ratio 4.71, P0.002). Age and sex-standardised mortality rates amon

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::a85ec96bd20fde1ea6b25029fd9dee57
https://pubmed.ncbi.nlm.nih.gov/17918662